Table 1 Clinical characteristics of included patients with mild and severe COVID-19
From: Serum neopterin levels in relation to mild and severe COVID-19
Mild disease (n = 15) | Severe disease (n = 19) | |
|---|---|---|
Gender (M/F) | 6/9 | 17/2 |
Age, years (SD) | 51.3 (13.7) | 61.3 (11.4) |
Comorbidity, n (%) | 2 (13) | 11 (58) |
Hypertension | 0 (0) | 11 (58) |
Diabetes mellitus | 1 (7) | 6 (32) |
Coronary heart disease | 1 (7) | 3 (16) |
Chronic obstructive pulmonary disease | 0 (0) | 1 (5) |
Asthma | 0 (0) | 1 (5) |
Symptoms, n (%) | ||
Fever | 9 (60) | 19 (100) |
Cough | 14 (93) | 18 (95) |
Dyspnea | 1 (7) | 17 (89) |
Fatigue | 3 (20) | 12 (63) |
Myalgia | 11 (73) | 5 (26) |
Sore throat | 8 (53) | 2 (11) |
Nasal congestion | 11 (73) | 1 (5) |
Intensive care, n (%) | 0 (0) | 17 (89) |
Invasive mechanical ventilation, n (%) | 0 (0) | 15 (79) |
Continuous renal replacement therapy, n (%) | 0 (0) | 3 (16) |
Death, n (%) | 0 (0) | 4 (21) |